Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Treatment Development for Alzheimer’s Disease: How Are We Doing?
Constantin George Lyketsos
School of Medicine
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment Development for Alzheimer’s Disease: How Are We Doing?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Alzheimer's Disease
100%
Treatment Development
100%
Dementia
50%
Alzheimer
50%
Brain Diseases
50%
Amyloid-β Protein
50%
Synaptic
25%
Aging
25%
Mild Cognitive Impairment
25%
Neuronal Loss
25%
Vascular Disease
25%
Most Common Cause
25%
Disease-associated
25%
Insulin Resistance
25%
Alzheimer's Dementia
25%
Prodrome
25%
World Population
25%
Low-middle Income Countries
25%
Causes of Dementia
25%
Brain Circuits
25%
Over 40
25%
Abeta
25%
Precision Medicine
25%
Brain Inflammation
25%
Amyloid Hypothesis
25%
Tau Protein
25%
Intraneuronal
25%
Hyperphosphorylation
25%
Brain Amyloid
25%
Amyloid PET
25%
Early Symptoms
25%
AD Treatment
25%
Medicine and Dentistry
Alzheimer's Disease
100%
Amyloid
100%
Treatment Development
100%
Symptom
50%
Brain Disease
50%
Amyloid Beta Protein
50%
Positron Emission Tomography
25%
Personalized Medicine
25%
Cerebrovascular Disease
25%
Mild Cognitive Impairment
25%
Low and Middle Income Countries
25%
Protein A
25%
Encephalitis
25%
Insulin Resistance
25%
Prodrome
25%
Hyperphosphorylation
25%
Tau Protein
25%
Neuroscience
Amyloid
100%
Alzheimer's Disease
100%
Treatment Development
100%
Encephalopathy
50%
Amyloid Beta Protein
50%
Mild Cognitive Impairment
25%
Positron Emission Tomography
25%
Tau Protein
25%
Protein A
25%
Cerebrovascular Disease
25%
Hyperphosphorylation
25%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Amyloid
100%
Symptom
50%
Brain Disease
50%
Amyloid Beta Protein
50%
Insulin Resistance
25%
Cerebrovascular Disease
25%
Encephalitis
25%
Mild Cognitive Impairment
25%
Tau Protein
25%
Protein A
25%